OpenAI pricing page lists unannounced gpt-rosalind-discovery model

A pricing page entry is a telling signal: OpenAI appears to be quietly expanding its Rosalind life-science line, and the identical rates suggest a tiered or companion offering rather than a premium product. The gating to approved institutions means this stays confined to research users, not general API customers, so the near-term market impact is narrow. What is worth watching is whether OpenAI confirms the model and how the discovery variant differs from the research one; the billing start for the research version implies the commercial framework is already live.